Insider Trading activities at Gilead Sciences, Inc. (GILD)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gilead Sciences, Inc. (GILD) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gilead Sciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 882095.

Total stock buying since 2015: $999,150.
Total stock sales since 2015: $904,439,192.
Total stock option exercises since 2015: $229,467,536.


 1   2   3   4 
33 insiders reported insider trading activities at Gilead Sciences, Inc. (GILD):
Insider trading activities of Manwani Harish
Insider trading activities of Moore Nicholas G
Insider trading activities of Kramer Kelly A.
Insider trading activities of Wold Olsen Per
Insider trading activities of O'day Daniel Patrick
Insider trading activities of Young Kevin
Insider trading activities of Washington Robin L
Insider trading activities of Whitley Richard James
Insider trading activities of Horning Sandra
Insider trading activities of Wilson Gayle E
Insider trading activities of Hills Carla A
Insider trading activities of Davignon Etienne
Insider trading activities of Telman Deborah H
Insider trading activities of Barton Jacqueline K
Insider trading activities of Mercier Johanna
Insider trading activities of Pletcher Brett A
Insider trading activities of Martin John C
Insider trading activities of Meyers James R
Insider trading activities of Alton Gregg H
Insider trading activities of Rodriguez Javier
Insider trading activities of Wilfong Diane E.
Insider trading activities of Welters Anthony
Insider trading activities of Patterson Sandra
Insider trading activities of Lofton Kevin E
Insider trading activities of Parsey Merdad
Insider trading activities of Dickinson Andrew D
Insider trading activities of Bluestone Jeffrey
Insider trading activities of Mchutchison John G
Insider trading activities of Bischofberger Norbert W
Insider trading activities of Carter Paul Rutherford
Insider trading activities of Cogan John Francis
Insider trading activities of Milligan John F
Insider trading activities of Madigan John W

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Gilead Sciences, Inc. (GILD).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 435,785 $45,394,173 430,175 $23,889,837
2024 0 $0 553,812 $50,082,191 602,474 $29,785,219
2023 0 $0 32,096 $2,551,890 146,531 $442,191
2022 0 $0 26,355 $1,866,288 194,847 $828,297
2021 0 $0 66,560 $4,452,843 172,673 $1,756,865
2020 0 $0 137,004 $9,885,521 248,984 $3,686,488
2019 0 $0 128,408 $8,418,483 159,162 $2,742,587
2018 0 $0 926,935 $70,384,176 1,254,464 $30,546,376
2017 0 $0 1,447,128 $107,862,022 1,498,305 $32,405,995
2016 0 $0 2,050,842 $174,107,762 2,026,940 $36,648,094
2015 10,000 $999,150 4,020,793 $429,433,843 3,952,353 $66,735,587

Table 2. Monthly summary of insider trading at Gilead Sciences, Inc. (GILD).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-08 0 $0 40,500 $4,757,261 25,000 $1,666,000
2025-07 0 $0 31,500 $3,516,985 13,743 $337,250
2025-06 0 $0 15,500 $1,713,685 20,195 $0
2025-05 0 $0 40,500 $4,365,509 25,000 $1,666,000
2025-04 0 $0 2,500 $266,000 2,570 $0
2025-03 0 $0 20,429 $2,390,154 63,296 $1,103,393
2025-02 0 $0 140,176 $14,333,465 137,676 $9,845,210
2025-01 0 $0 144,680 $14,051,114 142,695 $9,271,984
2024-12 0 $0 8,500 $781,660 23,204 $0
2024-11 0 $0 450,234 $41,571,250 429,058 $28,337,219
2024-10 0 $0 2,000 $167,660 514 $0
2024-09 0 $0 50,603 $4,253,642 48,049 $1,448,000
2024-08 0 $0 15,003 $1,148,449 3,678 $0
2024-07 0 $0 2,000 $137,260 8,744 $0
2024-06 0 $0 0 $0 23,044 $0
2024-04 0 $0 2,000 $145,920 515 $0
2024-03 0 $0 0 $0 65,154 $0
2024-02 0 $0 10,230 $744,985 0 $0
2024-01 0 $0 13,242 $1,131,365 514 $0
2023-12 0 $0 0 $0 16,289 $0
2023-11 0 $0 0 $0 1,912 $0
2023-10 0 $0 5,000 $400,015 514 $0
2023-09 0 $0 1,501 $115,561 15,995 $0
2023-08 0 $0 0 $0 4,484 $0

Table 3. Detailed insider trading at Gilead Sciences, Inc. (GILD)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-08-28 O'day Daniel Patrick (Chairman & CEO) Sale 10,000 113.63 1,136,300
2025-08-15 Mercier Johanna (Chief Commercial Officer) Sale 28,000 118.74 3,324,636
2025-08-15 Mercier Johanna (Chief Commercial Officer) Option Ex 25,000 66.64 1,666,000
2025-08-15 Dickinson Andrew D (Chief Financial Officer) Sale 2,500 118.53 296,325
2025-07-28 O'day Daniel Patrick (Chairman & CEO) Sale 10,000 113.63 1,136,290
2025-07-25 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 8,743 .00 0
2025-07-15 Mercier Johanna (Chief Commercial Officer) Sale 6,000 111.03 666,180
2025-07-15 Dickinson Andrew D (Chief Financial Officer) Sale 5,000 111.03 555,150
2025-07-14 Bluestone Jeffrey (Director) Sale 5,000 109.74 548,700
2025-07-14 Bluestone Jeffrey (Director) Option Ex 5,000 67.45 337,250
2025-06-30 O'day Daniel Patrick (Chairman & CEO) Sale 10,000 110.78 1,107,750
2025-06-16 Mercier Johanna (Chief Commercial Officer) Sale 3,000 110.17 330,510
2025-06-16 Dickinson Andrew D (Chief Financial Officer) Sale 2,500 110.17 275,425
2025-06-10 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 1,313 .00 0
2025-06-10 Mercier Johanna (Chief Commercial Officer) Option Ex 3,843 .00 0
2025-06-10 O'day Daniel Patrick (Chairman & CEO) Option Ex 10,425 .00 0
2025-06-10 Wilfong Diane E. (Interim Corp Controller & CAO) Option Ex 920 .00 0
2025-06-10 Dickinson Andrew D (Chief Financial Officer) Option Ex 3,694 .00 0
2025-05-30 O'day Daniel Patrick (Chairman & CEO) Sale 10,000 110.54 1,105,400
2025-05-22 Mercier Johanna (Chief Commercial Officer) Sale 28,000 107.52 3,010,560
2025-05-22 Mercier Johanna (Chief Commercial Officer) Option Ex 25,000 66.64 1,666,000
2025-05-15 Dickinson Andrew D (Chief Financial Officer) Sale 2,500 99.82 249,549
2025-04-25 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 1,542 .00 0
2025-04-15 Dickinson Andrew D (Chief Financial Officer) Sale 2,500 106.40 266,000
2025-03-17 Dickinson Andrew D (Chief Financial Officer) Sale 2,500 110.53 276,325
2025-03-10 Patterson Sandra (SVP, Controllership) Option Ex 1,952 .00 0
2025-03-10 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 3,343 .00 0
2025-03-10 Mercier Johanna (Chief Commercial Officer) Option Ex 8,080 .00 0
2025-03-10 O'day Daniel Patrick (Chairman & CEO) Option Ex 24,024 .00 0
2025-03-10 Dickinson Andrew D (Chief Financial Officer) Sale 17,929 117.90 2,113,829
2025-03-10 Dickinson Andrew D (Chief Financial Officer) Option Ex 25,897 42.61 1,103,393
2025-02-18 Dickinson Andrew D (Chief Financial Officer) Sale 2,500 104.09 260,225
2025-02-12 Dickinson Andrew D (Chief Financial Officer) Sale 137,676 102.22 14,073,240
2025-02-12 Dickinson Andrew D (Chief Financial Officer) Option Ex 137,676 71.51 9,845,210
2025-01-31 Dickinson Andrew D (Chief Financial Officer) Sale 142,180 97.22 13,822,739
2025-01-31 Dickinson Andrew D (Chief Financial Officer) Option Ex 142,180 65.21 9,271,984
2025-01-25 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 515 .00 0
2025-01-15 Dickinson Andrew D (Chief Financial Officer) Sale 2,500 91.35 228,375
2024-12-16 Dickinson Andrew D (Chief Financial Officer) Sale 8,500 91.96 781,660
2024-12-13 Patterson Sandra (SVP, Controllership) Option Ex 157 .00 0
2024-12-10 Patterson Sandra (SVP, Controllership) Option Ex 901 .00 0
2024-12-10 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 639 .00 0
2024-12-10 Parsey Merdad (Chief Medical Officer) Option Ex 3,820 .00 0
2024-12-10 Mercier Johanna (Chief Commercial Officer) Option Ex 3,752 .00 0
2024-12-10 O'day Daniel Patrick (Chairman & CEO) Option Ex 10,295 .00 0
2024-12-10 Dickinson Andrew D (Chief Financial Officer) Option Ex 3,640 .00 0
2024-11-29 Dickinson Andrew D (Chief Financial Officer) Sale 248,645 92.76 23,065,304
2024-11-29 Dickinson Andrew D (Chief Financial Officer) Option Ex 248,645 69.62 17,311,908
2024-11-27 Parsey Merdad (Chief Medical Officer) Sale 164,211 91.88 15,087,706
2024-11-27 Parsey Merdad (Chief Medical Officer) Option Ex 145,413 61.65 8,964,711
2024-11-26 Bluestone Jeffrey (Director) Sale 6,788 91.39 620,355
2024-11-26 Bluestone Jeffrey (Director) Option Ex 10,000 61.26 612,600
2024-11-06 Parsey Merdad (Chief Medical Officer) Sale 25,590 91.50 2,341,485
2024-11-06 Parsey Merdad (Chief Medical Officer) Option Ex 25,000 57.92 1,448,000
2024-11-06 Mercier Johanna (Chief Commercial Officer) Sale 5,000 91.28 456,400
2024-10-25 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 514 .00 0
2024-10-01 Parsey Merdad (Chief Medical Officer) Sale 2,000 83.83 167,660
2024-09-12 Parsey Merdad (Chief Medical Officer) Sale 21,246 84.50 1,795,287
2024-09-12 Parsey Merdad (Chief Medical Officer) Option Ex 25,000 57.92 1,448,000
2024-09-12 Mercier Johanna (Chief Commercial Officer) Sale 29,357 83.74 2,458,355
2024-09-10 Patterson Sandra (SVP, Controllership) Option Ex 901 .00 0
2024-09-10 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 639 .00 0
2024-09-10 Parsey Merdad (Chief Medical Officer) Option Ex 3,821 .00 0
2024-09-10 Mercier Johanna (Chief Commercial Officer) Option Ex 3,752 .00 0
2024-09-10 O'day Daniel Patrick (Chairman & CEO) Option Ex 10,295 .00 0
2024-09-10 Dickinson Andrew D (Chief Financial Officer) Option Ex 3,641 .00 0
2024-08-28 Mercier Johanna (Chief Commercial Officer) Sale 9,513 78.03 742,299
2024-08-13 Mercier Johanna (Chief Commercial Officer) Sale 5,490 73.98 406,150
2024-08-10 Patterson Sandra (SVP, Controllership) Option Ex 3,678 .00 0
2024-07-25 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 8,744 .00 0
2024-07-01 Parsey Merdad (Chief Medical Officer) Sale 2,000 68.63 137,260
2024-06-10 Patterson Sandra (SVP, Controllership) Option Ex 901 .00 0
2024-06-10 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 638 .00 0
2024-06-10 Parsey Merdad (Chief Medical Officer) Option Ex 3,820 .00 0
2024-06-10 Mercier Johanna (Chief Commercial Officer) Option Ex 3,751 .00 0
2024-06-10 O'day Daniel Patrick (Chairman & CEO) Option Ex 10,295 .00 0
2024-06-10 Dickinson Andrew D (Chief Financial Officer) Option Ex 3,639 .00 0
2024-04-25 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 515 .00 0
2024-04-01 Parsey Merdad (Chief Medical Officer) Sale 2,000 72.96 145,920
2024-03-10 Patterson Sandra (SVP, Controllership) Option Ex 2,682 .00 0
2024-03-10 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 2,555 .00 0
2024-03-10 Parsey Merdad (Chief Medical Officer) Option Ex 10,401 .00 0
2024-03-10 Mercier Johanna (Chief Commercial Officer) Option Ex 9,844 .00 0
2024-03-10 O'day Daniel Patrick (Chairman & CEO) Option Ex 29,940 .00 0
2024-03-10 Dickinson Andrew D (Chief Financial Officer) Option Ex 9,732 .00 0
2024-02-29 Parsey Merdad (Chief Medical Officer) Sale 8,230 72.74 598,625
2024-02-28 Parsey Merdad (Chief Medical Officer) Sale 2,000 73.18 146,360
2024-01-25 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 514 .00 0
2024-01-16 Dickinson Andrew D (Chief Financial Officer) Sale 5,000 85.78 428,900
2024-01-09 Mercier Johanna (Chief Commercial Officer) Sale 8,242 85.23 702,465
2023-12-13 Patterson Sandra (SVP, Controllership) Option Ex 298 .00 0
2023-12-10 Patterson Sandra (SVP, Controllership) Option Ex 518 .00 0
2023-12-10 Parsey Merdad (Chief Medical Officer) Option Ex 2,779 .00 0
2023-12-10 Mercier Johanna (Chief Commercial Officer) Option Ex 2,730 .00 0
2023-12-10 O'day Daniel Patrick (Chairman & CEO) Option Ex 7,347 .00 0
2023-12-10 Dickinson Andrew D (Chief Financial Officer) Option Ex 2,617 .00 0
2023-11-10 Dickinson Andrew D (Chief Financial Officer) Option Ex 1,912 .00 0
2023-10-25 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 514 .00 0
2023-10-17 Dickinson Andrew D (Chief Financial Officer) Sale 5,000 80.00 400,015
2023-09-12 Parsey Merdad (Chief Medical Officer) Sale 1,501 76.99 115,561
2023-09-10 Patterson Sandra (SVP, Controllership) Option Ex 519 .00 0
2023-09-10 Parsey Merdad (Chief Medical Officer) Option Ex 2,779 .00 0
2023-09-10 Mercier Johanna (Chief Commercial Officer) Option Ex 2,730 .00 0
2023-09-10 O'day Daniel Patrick (Chairman & CEO) Option Ex 7,348 .00 0
2023-09-10 Dickinson Andrew D (Chief Financial Officer) Option Ex 2,619 .00 0
2023-08-10 Patterson Sandra (SVP, Controllership) Option Ex 4,484 .00 0
2023-07-25 Telman Deborah H (EVP, Corporate Affairs & GC) Option Ex 10,289 .00 0
2023-07-24 Mercier Johanna (Chief Commercial Officer) Option Ex 7,505 .00 0
2023-07-20 Dickinson Andrew D (Chief Financial Officer) Sale 5,000 80.00 400,000
2023-06-13 Parsey Merdad (Chief Medical Officer) Sale 1,485 76.90 114,196
2023-03-13 Parsey Merdad (Chief Medical Officer) Sale 6,126 78.99 483,892
2023-03-10 Patterson Sandra (SVP, Controllership) Option Ex 2,921 .00 0
2023-03-10 Parsey Merdad (Chief Medical Officer) Option Ex 11,454 .00 0
2023-03-10 Mercier Johanna (Chief Commercial Officer) Option Ex 10,976 .00 0
2023-03-10 O'day Daniel Patrick (Chairman & CEO) Option Ex 30,288 .00 0
2023-03-10 Dickinson Andrew D (Chief Financial Officer) Option Ex 10,419 .00 0
2023-03-09 Lofton Kevin E (Director) Option Ex 8,442 52.38 442,191
2023-03-01 Parsey Merdad (Chief Medical Officer) Sale 12,984 79.96 1,038,226
2023-03-01 O'day Daniel Patrick (Chairman & CEO) Option Ex 11,362 .00 0
2023-02-06 Wilfong Diane E. (SVP, Controller & CAO) Option Ex 1,864 .00 0
2023-02-06 Dickinson Andrew D (Chief Financial Officer) Option Ex 1,817 .00 0
2022-12-30 Parsey Merdad (Chief Medical Officer) Sale 553 85.33 47,187
2022-12-10 Parsey Merdad (Chief Medical Officer) Option Ex 1,039 .00 0
2022-12-10 Mercier Johanna (Chief Commercial Officer) Option Ex 990 .00 0
2022-12-10 O'day Daniel Patrick (Chairman & CEO) Option Ex 3,300 .00 0
2022-12-10 Wilfong Diane E. (SVP, Controller & CAO) Option Ex 318 .00 0
2022-12-10 Dickinson Andrew D (Chief Financial Officer) Option Ex 1,027 .00 0
2022-11-10 Parsey Merdad (Chief Medical Officer) Option Ex 5,099 .00 0
2022-11-10 Dickinson Andrew D (Chief Financial Officer) Option Ex 1,912 .00 0
2022-11-09 Wilfong Diane E. (SVP, Controller & CAO) Sale 6,416 83.50 535,736
2022-11-09 Wilfong Diane E. (SVP, Controller & CAO) Option Ex 6,416 63.91 410,046
2022-09-10 Parsey Merdad (Chief Medical Officer) Option Ex 1,039 .00 0
2022-09-10 Mercier Johanna (Chief Commercial Officer) Option Ex 990 .00 0
2022-09-10 O'day Daniel Patrick (Chairman & CEO) Option Ex 3,301 .00 0
2022-09-10 Wilfong Diane E. (SVP, Controller & CAO) Option Ex 318 .00 0
2022-09-10 Dickinson Andrew D (Chief Financial Officer) Option Ex 1,027 .00 0
2022-08-10 Wilfong Diane E. (SVP, Controller & CAO) Option Ex 2,479 .00 0
2022-07-24 Mercier Johanna (Chief Commercial Officer) Option Ex 7,505 .00 0
2022-06-10 Parsey Merdad (Chief Medical Officer) Option Ex 1,039 .00 0
2022-06-10 Mercier Johanna (Chief Commercial Officer) Option Ex 990 .00 0
2022-06-10 Pletcher Brett A (EVP,Corp Affairs & Gen Counsel) Option Ex 782 .00 0
2022-06-10 O'day Daniel Patrick (Chairman & CEO) Option Ex 3,300 .00 0
2022-06-10 Wilfong Diane E. (SVP, Controller & CAO) Option Ex 317 .00 0
2022-06-10 Dickinson Andrew D (Chief Financial Officer) Option Ex 4,672 .00 0
2022-05-03 Bluestone Jeffrey (Director) Option Ex 2,223 .00 0
2022-05-03 Horning Sandra (Director) Option Ex 1,112 .00 0
2022-05-03 Manwani Harish (Director) Option Ex 2,223 .00 0
2022-05-03 Lofton Kevin E (Director) Option Ex 2,223 .00 0
2022-05-03 Rodriguez Javier (Director) Option Ex 2,223 .00 0
2022-05-03 Welters Anthony (Director) Option Ex 2,223 .00 0
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of GILD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gilead Sciences, Inc. (symbol GILD, CIK number 882095) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.